Literature DB >> 7801621

Seroreversion in patients with end-stage HIV infection.

M Gutiérrez, V Soriano, R Bravo, A Vallejo, J Gonzalez-Lahoz.   

Abstract

Entities:  

Mesh：

Year:  1994        PMID： 7801621     DOI： 10.1111/j.1423-0410.1994.tb01669.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN： 0042-9007            Impact factor:   2.144


× No keyword cloud information.
  5 in total

1.  Helios expressing regulatory T cells are correlated with decreased IL-2 producing CD8 T cells and antibody diversity in Mozambican individuals living chronically with HIV-1.

Authors:  Raquel Matavele Chissumba; Cacildo Magul; Rosa Macamo; Vânia Monteiro; Maria Enosse; Ivalda Macicame; Victória Cumbane; Nilesh Bhatt; Edna Viegas; Michelle Imbach; Leigh Anne Eller; Christina S Polyak; Luc Kestens
Journal:  BMC Immunol       Date:  2022-03-14       Impact factor: 3.615

2.  Absence of seroreversion in 80 HAART-treated HIV-1 seropositive patients with at least five-years undetectable plasma HIV-1 viral load.

Authors:  Marion Cornelissen; Suzanne Jurriaans; Jan M Prins; Margreet Bakker; Antoinette C van der Kuyl
Journal:  AIDS Res Ther       Date:  2006-02-16       Impact factor: 2.250

3.  Serodeconversion of HIV antibody-positive AIDS patients following treatment with V-1 Immunitor.

Authors:  Orapun Metadilogkul; Vichai Jirathitikal; Aldar S Bourinbaiar
Journal:  J Biomed Biotechnol       Date:  2008-10-28

Review 4.  Translational HIV-1 research: from routine diagnostics to new virology insights in Amsterdam, the Netherlands during 1983-2013.

Authors:  Antoinette C van der Kuyl; Margreet Bakker; Suzanne Jurriaans; Nicole K T Back; Alexander O Pasternak; Marion Cornelissen; Ben Berkhout
Journal:  Retrovirology       Date:  2013-08-28       Impact factor: 4.602

5.  HIV seronegativity in children, adolescents and young adults living with perinatally acquired HIV: A cross-sectional study in Thailand.

Authors:  Praew Wirotpaisankul; Keswadee Lapphra; Alan Maleesatharn; Supattra Rungmaitree; Orasri Wittawatmongkol; Wanatpreeya Phongsamart; Nantaka Kongstan; Benjawan Khumcha; Kulkanya Chokephaibulkit
Journal:  J Int AIDS Soc       Date:  2020-09       Impact factor: 5.396
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.